Govt Job: Walk in interview for Pharmacist at PGIMER

The PGIMER owes its inception to the vision of late Sardar Partap Singh Kairon, the then Chief Minister of Punjab and the distinguished medical educationists of the then combined state of Punjab, supported by the first Prime Minister of India Pt. Jawahar Lal Nehru who considered the institutions of scientific knowledge as temples of learning and the places of pilgrimage.

Post : Pharmacist

Project Title : A PHASE 2/3, OBSERVER-BLIND, RANDOMIZED, CONTROLLED STUDY TO DETERMINE THE SAFETY AND IMMUNOGENICITY OF COVOVAX [SARS-CoV-2 RECOMBINANT SPIKE PROTEIN NANOPARTICLE VACCINE (SARS- CoV-2 rS) WITH MATRJX-M1 ™ ADJUVANT| IN INDIAN ADULTS AGED > 18 YEARS AND CHILDREN AGED 2 TO 17 YEARS

Qualification : Essential B.Pharma / Diploma in pharmacy from a recognized institution / board, should be a registered pharmacist under the pharmacy act 1948 – Minimum 1 year of experience in dispensing and /or storage and dispensing of drugs in a reputed hospital or institution or in a drug stores of a pharmaceutical concern / Clinical research experience.

Tenure : 3 months

Salary : 33,300/-

Date of Interview : 03rd  September,2021 (Friday)

Time of Interview : 03:00 pm

Selection Process :  An online interview will be conducted on 03ri1 September 2021 at 3:00 PM via zoom/Google meet. In view of C-19, no face to face Interview will be conducted.

How to apply : Interested candidate should email their applications along with their curriculum vitae (softcopy of resume) with supporting documents address to Dr, Madhu Gupta, Professor on email ID : covovax2021@gmail.com

Last date: before 05:00 PM dated 31/08/2021. No applications will be entertained after 05:00 PM on 31/08/2021

Related Posts

Andelyn Biosciences partners with Queen’s University to develop and manufacture gene therapy AAV9-GM2 to treat GM2 gangliosidoses

Andelyn bio sciences Inc, a leading patient-focused cell and gene therapy Contract Development and Manufacturing Organization (CDMO), has partnered with Queen’s University to develop and manufacture AAV9-GM2, a gene therapy…

Cellution Biologics completes acquisition of SimpliDerm business for US$ 8 million from Elutia

Cellution Biologics Inc, a biologics company focused on developing, manufacturing and commercializing advanced human tissue-based products, announced the completion of its acquisition of the SimpliDerm hydrated human acellular dermal matrix…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Andelyn Biosciences partners with Queen’s University to develop and manufacture gene therapy AAV9-GM2 to treat GM2 gangliosidoses

Andelyn Biosciences partners with Queen’s University to develop and manufacture gene therapy AAV9-GM2 to treat GM2 gangliosidoses

Cellution Biologics completes acquisition of SimpliDerm business for US$ 8 million from Elutia

Cellution Biologics completes acquisition of SimpliDerm business for US$ 8 million from Elutia

ACB Gujarat arrested two FDA Officials red-handed in Bharuch accepting a bribe of ₹40,000

ACB Gujarat arrested two FDA Officials red-handed in Bharuch accepting a bribe of ₹40,000

US appeals court sides with Sun Pharma in Lipitor antitrust case

US appeals court sides with Sun Pharma in Lipitor antitrust case

Counterfeit Cosmetics Are No Longer a Fringe Problem: 4 in 10 Consumers Report Fake Products, Regulatory Silence Raises Serious Questions

Counterfeit Cosmetics Are No Longer a Fringe Problem: 4 in 10 Consumers Report Fake Products, Regulatory Silence Raises Serious Questions

Three arrested for illegal sale of mephentermine sulphate injections in Hyderabad

Three arrested for illegal sale of mephentermine sulphate injections in Hyderabad